Results 111 to 120 of about 8,048 (187)

Pulmonary hypertension caused by pulmonary venous hypertension [PDF]

open access: yes, 2015
The effect of pulmonary venous hypertension (PVH) on the pulmonary circulation is extraordinarily variable, ranging from no impact on pulmonary vascular resistance (PVR) to a marked increase. The reasons for this are unknown.
Kulik, Thomas J.
core   +1 more source

United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications

open access: yesPulmonary Circulation, 2019
Diagnostic World Health Organization (WHO) Group 1 pulmonary arterial hypertension (PAH) and Diagnostic Group 1' pulmonary veno-occlusive disease (PVOD) and/or pulmonary capillary hemangiomatosis (PCH) are progressive and fatal disorders. Past registries
C. Gregory Elliott   +13 more
doaj   +1 more source

Heritable pulmonary hypertension: from bench to bedside

open access: yesEuropean Respiratory Review, 2017
Mutations in the BMPR2 gene, and more rarely in ACVRL1, endoglin, caveolin-1, KCNK3 and TBX4 genes predispose to heritable pulmonary arterial hypertension, an autosomal dominant disease with incomplete penetrance. Bi-allelic mutations in the EIF2AK4 gene
Barbara Girerd   +3 more
doaj   +1 more source

Exercise-induced pulmonary hemorrhage: where are we now? [PDF]

open access: yes, 2016
Citation: Poole, D. C., & Erickson, H. H. (2016). Exercise-induced pulmonary hemorrhage: where are we now? Veterinary Medicine-Research and Reports, 7, 133-148.
Erickson, Howard H., Poole, David C.
core   +1 more source

Reduced Toxicity Conditioning with Busulfan, Fludarabine, Alemtuzumab and Allogeneic Stem Cell Transplantation From HLA-Matched Sibling Donors in Children with High Risk Sickle Cell Disease Results in Long Term Donor Chimerism and Low Incidence of aGVHD [PDF]

open access: yes, 2013
Purpose It is still equivocal whether oxygen uptake recovery kinetics are limited by oxygen delivery and can be improved by supplementary oxygen. The present study aimed to investigate whether measurements of muscle and pulmonary oxygen uptake kinetics ...
Jansen, J.P.   +5 more
core   +6 more sources

Comprehensive three‐dimensional morphology of neoangiogenesis in pulmonary veno‐occlusive disease and pulmonary capillary hemangiomatosis

open access: yesThe Journal of Pathology: Clinical Research, 2019
Pulmonary veno‐occlusive disease (PVOD) is a rare lung disease characterized by fibrotic narrowing of pulmonary veins leading to pulmonary hypertension (PH) and finally to death by right heart failure.
Lavinia Neubert   +12 more
doaj   +1 more source

Hepatic complications of allogeneic hematopoietic cell transplantation [PDF]

open access: yes, 2008
Hepatic complications of allogeneic hematopoietic cell transplantation contribute substantially to the overall success of the procedure and represent a major cause of morbidity and mortality.
Mutlu Arat, Ramazan Idilman
core  

Radiological conference. Pulmonary arterial hypertension [PDF]

open access: yes, 1997
published_or_final_versio
Peh, WCG
core  

Deep vein thrombosis and pulmonary embolism in the Chinese population [PDF]

open access: yes, 1998
Deep vein thrombosis and pulmonary embolism is a well-recognised major health problem in the West. There is a deep-rooted belief among clinicians that deep vein thrombosis is rare in Asians, particularly in the Chinese population.
Chan, HT   +4 more
core  

Home - About - Disclaimer - Privacy